|
1
|
Chou CT, Yang JS and Lee MR: Apoptosis in
rheumatoid arthritis-expression of Fas, Fas-L, p53, and Bcl-2 in
rheumatoid synovial tissues. J Pathol. 193:110–116. 2001.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Tak PP, Zvaifler NJ, Green DR and
Firestein GS: Rheumatoid arthritis and p53: How oxidative stress
might alter the course of inflammatory diseases. Immunol Today.
21:78–82. 2000.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Yamanishi Y, Boyle DL, Rosengren S, Green
DR, Zvaifler NJ and Firestein GS: Regional analysis of p53
mutations in rheumatoid arthritis synovium. Proc Natl Acad Sci USA.
99:10025–10030. 2002.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Bustamante MF, Garcia-Carbonell R,
Whisenant KD and Guma M: Fibroblast-like synoviocyte metabolism in
the pathogenesis of rheumatoid arthritis. Arthritis Res Ther.
19(110)2017.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Migone TS, Zhang J, Luo X, Zhuang L, Chen
C, Hu B, Hong JS, Perry JW, Chen SF, Zhou JX, et al: TL1A is a
TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell
costimulator. Immunity. 16:479–492. 2002.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Kamada N, Hisamatsu T, Honda H, Kobayashi
T, Chinen H, Takayama T, Kitazume MT, Okamoto S, Koganei K, Sugita
A, et al: TL1A produced by lamina propria macrophages induces Th1
and Th17 immune responses in cooperation with IL-23 in patients
with Crohn's disease. Inflamm Bowel Dis. 16:568–575.
2010.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Bamias G, Martin C III, Marini M, Hoang S,
Mishina M, Ross WG, Sachedina MA, Friel CM, Mize J, Bickston SJ, et
al: Expression, localization, and functional activity of TL1A, a
novel Th1-polarizing cytokine in inflammatory bowel disease. J
Immunol. 171:4868–4874. 2003.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Prehn JL, Mehdizadeh S, Landers CJ, Luo X,
Cha SC, Wei P and Targan SR: Potential role for TL1A, the new
TNF-family member and potent costimulator of IFN-gamma, in mucosal
inflammation. Clin Immunol. 112:66–77. 2004.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Papadakis KA, Zhu D, Prehn JL, Landers C,
Avanesyan A, Lafkas G and Targan SR: Dominant role for TL1A/DR3
pathway in IL-12 plus IL-18-induced IFN-gamma production by
peripheral blood and mucosal CCR9+ T lymphocytes. J Immunol.
174:4985–4990. 2005.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Cassatella MA, Pereira-da-Silva G, Tinazzi
I, Facchetti F, Scapini P, Calzetti F, Tamassia N, Wei P, Nardelli
B, Roschke V, et al: Soluble TNF-like cytokine (TL1A) production by
immune complexes stimulated monocytes in rheumatoid arthritis. J
Immunol. 178:7325–7333. 2007.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Prehn JL, Thomas LS, Landers CJ, Yu QT,
Michelsen KS and Targan SR: The T cell costimulator TL1A is induced
by FcgammaR signaling in human monocytes and dendritic cells. J
Immunol. 178:4033–4038. 2007.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Zhang J, Wang X, Fahmi H, Wojcik S, Fikes
J, Yu Y, Wu J and Luo H: Role of TL1A in the pathogenesis of
rheumatoid arthritis. J Immunol. 183:5350–5357. 2009.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Sethi G, Sung B and Aggarwal BB:
Therapeutic potential of VEGI/TL1A in autoimmunity and cancer. Adv
Exp Med Biol. 647:207–215. 2009.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Bamias G, Siakavellas SI, Stamatelopoulos
KS, Chryssochoou E, Papamichael C and Sfikakis PP: Circulating
levels of TNF-like cytokine 1A (TL1A) and its decoy receptor 3
(DcR3) in rheumatoid arthritis. Clin Immunol. 129:249–255.
2008.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Ma Z, Wang B, Wang M, Sun X, Tang Y, Li M,
Li F and Li X: TL1A increased IL-6 production on fibroblast-like
synoviocytes by preferentially activating TNF receptor 2 in
rheumatoid arthritis. Cytokine. 83:92–98. 2016.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Shi G, Wu Y, Zhang J and Wu J: Death decoy
receptor TR6/DcR3 inhibits T cell chemotaxis in vitro and in vivo.
J Immunol. 171:3407–3414. 2003.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Pitti RM, Marsters SA, Lawrence DA, Roy M,
Kischkel FC, Dowd P, Huang A, Donahue CJ, Sherwood SW, Baldwin DT,
et al: Genomic amplification of a decoy receptor for Fas ligand in
lung and colon cancer. Nature. 396:699–703. 1998.PubMed/NCBI View
Article : Google Scholar
|
|
18
|
Tsuji S, Hosotani R, Yonehara S, Masui T,
Tulachan SS, Nakajima S, Kobayashi H, Koizumi M, Toyoda E, Ito D,
et al: Endogenous decoy receptor 3 blocks the growth inhibition
signals mediated by Fas ligand in human pancreatic adenocarcinoma.
Int J Cancer. 106:17–25. 2003.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Yu KY, Kwon B, Ni J, Zhai Y, Ebner R and
Kwon BS: A newly identified member of tumor necrosis factor
receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis. J
Biol Chem. 274:13733–13736. 1999.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Hayashi S, Miura Y, Nishiyama T, Mitani M,
Tateishi K, Sakai Y, Hashiramoto A, Kurosaka M, Shiozawa S and
Doita M: Decoy receptor 3 expressed in rheumatoid synovial
fibroblasts protects the cells against Fas-induced apoptosis.
Arthritis Rheum. 56:1067–1075. 2007.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Takahashi M, Miura Y, Hayashi S, Tateishi
K, Fukuda K and Kurosaka M: DcR3-TL1A signalling inhibits
cytokine-induced proliferation of rheumatoid synovial fibroblasts.
Int J Mol Med. 28:423–427. 2011.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Fukuda K, Miura Y, Maeda T, Takahashi M,
Hayashi S and Kurosaka M: Decoy receptor 3 regulates the expression
of various genes in rheumatoid arthritis synovial fibroblasts. Int
J Mol Med. 32:910–916. 2013.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Fukuda K, Miura Y, Maeda T, Hayashi S and
Kurosaka M: Interleukin12B is upregulated by decoy receptor 3 in
rheumatoid synovial fibroblasts. Mol Med Rep. 13:3647–3652.
2016.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Maeda T, Miura Y, Fukuda K, Hayashi S and
Kurosaka M: Decoy receptor 3 regulates the expression of tryptophan
hydroxylase 1 in rheumatoid synovial fibroblasts. Mol Med Rep.
12:5191–5196. 2015.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Fukuda K, Miura Y, Maeda T, Hayashi S and
Kuroda R: Decoy receptor 3 down-regulates centrosomal protein 70
kDa specifically in rheumatoid synovial fibroblasts. Mod Rheumatol.
28:287–292. 2018.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Arnett FC, Edworthy SM, Bloch DA, McShane
DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH and Luthra
HS: The American Rheumatism Association 1987 revised criteria for
the classification of rheumatoid arthritis. Arthritis Rheum.
31:315–324. 1988.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Choi YJ and Yun HK: Transcriptional
profiles of Rhizobium vitis-inoculated and salicylic acid-treated
‘Tamnara’ grapevines based on microarray analysis. J Plant
Biotechnol. 43:37–48. 2016. View Article : Google Scholar
|
|
28
|
Chang YC, Chen TC, Lee CT, Yang CY, Wang
HW, Wang CC and Hsieh SL: Epigenetic control of MHC class II
expression in tumor-associated macrophages by decoy receptor 3.
Blood. 111:5054–5063. 2008.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Espinosa I, Catasus L, Canet B, D'Angelo
E, Muñoz J and Prat J: Gene expression analysis identifies two
groups of ovarian high-grade serous carcinomas with different
prognosis. Mod Pathol. 24:846–854. 2011.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Khan J, Simon R, Bittner M, Chen Y,
Leighton SB, Pohida T, Smith PD, Jiang Y, Gooden GC, Trent JM and
Meltzer PS: Gene expression profiling of alveolar rhabdomyosarcoma
with cDNA microarrays. Cancer Res. 58:5009–5013. 1998.PubMed/NCBI
|
|
31
|
Whitney LW, Becker KG, Tresser NJ,
Caballero-Ramos CI, Munson PJ, Prabhu VV, Trent JM, McFarland HF
and Biddison WE: Analysis of gene expression in mutiple sclerosis
lesions using cDNA microarrays. Ann Neurol. 46:425–428.
1999.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Li J, Yang S, Lu S, Zhao H, Feng J, Li W,
Ma F, Ren Q, Liu B, Zhang L, et al: Differential gene expression
profile associated with the abnormality of bone marrow mesenchymal
stem cells in aplastic anemia. PLoS One. 7(e47764)2012.PubMed/NCBI View Article : Google Scholar
|
|
33
|
van der Pouw Kraan TC, van Gaalen FA,
Kasperkovitz PV, Verbeet NL, Smeets TJ, Kraan MC, Fero M, Tak PP,
Huizinga TW, Pieterman E, et al: Rheumatoid arthritis is a
heterogeneous disease: Evidence for differences in the activation
of the STAT-1 pathway between rheumatoid tissues. Arthritis Rheum.
48:2132–2145. 2003.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Lee SK, Jeon EK, Kim YJ, Seo SH, Kim CD,
Lim JS and Lee JH: A global gene expression analysis of the
peripheral blood mononuclear cells reveals the gene expression
signature in psoriasis. Ann Dermatol. 21:237–242. 2009.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Heller RA, Schena M, Chai A, Shalon D,
Bedilion T, Gilmore J, Woolley DE and Davis RW: Discovery and
analysis of inflammatory disease-related genes using cDNA
microarrays. Proc Natl Acad Sci USA. 94:2150–2155. 1997.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Gough LL, Fan J, Chu S, Winnick S and Beck
KA: Golgi localization of Syne-1. Mol Biol Cell. 14:2410–2424.
2003.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Apel ED, Lewis RM, Grady RM and Sanes JR:
Syne-1, a dystrophin- and Klarsicht-related protein associated with
synaptic nuclei at the neuromuscular junction. J Biol Chem.
275:31986–31995. 2000.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Fan J and Beck KA: A role for the spectrin
superfamily member Syne-1 and kinesin II in cytokinesis. J Cell
Sci. 117:619–629. 2004.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Yang W, Zheng H, Wang Y, Lian F, Hu Z and
Xue S: Nesprin-1 plays an important role in the proliferation and
apoptosis of mesenchymal stem cells. Int J Mol Med. 32:805–812.
2013.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Davis RS: Fc receptor-like molecules. Annu
Rev Immunol. 25:525–560. 2007.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Shabani M, Bayat AA, Jeddi-Tehrani M,
Rabbani H, Hojjat-Farsangi M, Ulivieri C, Amirghofran Z, Baldari CT
and Shokri F: Ligation of human Fc receptor like-2 by monoclonal
antibodies down-regulates B-cell receptor-mediated signalling.
Immunology. 143:341–353. 2014.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Nückel H, Collins CH, Frey UH, Sellmann L,
Dürig J, Siffert W and Dührsen U: FCRL2 mRNA expression is
inversely associated with clinical progression in chronic
lymphocytic leukemia. Eur J Haematol. 83:541–549. 2009.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Jackson TA, Haga CL, Ehrhardt GR, Davis RS
and Cooper MD: FcR-like 2 Inhibition of B cell receptor-mediated
activation of B cells. J Immunol. 185:7405–7412. 2010.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Li FJ, Ding S, Pan J, Shakhmatov MA,
Kashentseva E, Wu J, Li Y, Soong SJ, Chiorazzi N and Davis RS:
FCRL2 expression predicts IGHV mutation status and clinical
progression in chronic lymphocytic leukemia. Blood. 112:179–187.
2008.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Stamatopoulos B, Haibe-Kains B, Equeter C,
Meuleman N, Sorée A, De Bruyn C, Hanosset D, Bron D, Martiat P and
Lagneaux L: Gene expression profiling reveals differences in
microenvironment interaction between patients with chronic
lymphocytic leukemia expressing high versus low ZAP70 mRNA.
Haematologica. 94:790–799. 2009.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Khanzadeh A, Habibagahi Z, Hosseini A and
Amirghofran Z: Investigation of the human FCRL1, 2, and 4 gene
expressions in patients with rheumatoid arthritis. Rheumatol Int.
36:1149–1156. 2016.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Stehlik C, Krajewska M, Welsh K, Krajewski
S, Godzik A and Reed JC: The PAAD/PYRIN-only protein POP1/ASC2 is a
modulator of ASC-mediated nuclear-factor-kappa B and pro-caspase-1
regulation. Biochem J. 373:101–113. 2003.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Stehlik C: The PYRIN domain in signal
transduction. Curr Protein Pept Sci. 8:293–310. 2007.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Martinon F and Tschopp J: Inflammatory
caspases: Linking an intracellular innate immune system to
autoinflammatory diseases. Cell. 117:561–574. 2004.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Hopwood B and Dalton S: Cdc45p assembles
into a complex with Cdc46p/Mcm5p, is required for minichromosome
maintenance, and is essential for chromosomal DNA replication. Proc
Natl Acad Sci USA. 93:12309–12314. 1996.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Sun J, Shi R, Zhao S, Li X, Lu S, Bu H and
Ma X: Cell division cycle 45 promotes papillary thyroid cancer
progression via regulating cell cycle. Tumour Biol.
39(1010428317705342)2017.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Pollok S, Bauerschmidt C, Sänger J,
Nasheuer HP and Grosse F: Human Cdc45 is a proliferation-associated
antigen. FEBS J. 274:3669–3684. 2007.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Wang Y, Duan X and Zhang Z: Interleukin-1
receptor-associated kinase 1 correlates with metastasis and
invasion in endometrial carcinoma. J Cell Biochem. 119:2545–2555.
2018.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Majri SS, Fritz JM, Villarino AV, Zheng L,
Kanellopoulou C, Chaigne-Delalande B, Grönholm J, Niemela JE,
Afzali B, Biancalana M, et al: STAT5B: A differential regulator of
the life and death of CD4+ effector memory T cells. J
Immunol. 200:110–118. 2018.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Darnell JE Jr: STATs gene regulation.
Science. 277:1630–1635. 1997.PubMed/NCBI View Article : Google Scholar
|
|
56
|
O'Shea JJ, Lahesmaa R, Vahedi G, Laurence
A and Kanno Y: Genomic views of STAT function in CD4+ T helper cell
differentiation. Nat Rev Immunol. 11:239–250. 2011.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Villarino AV, Kanno Y, Ferdinand JR and
O'Shea JJ: Mechanisms of Jak/STAT signaling in immunity and
disease. J Immunol. 194:21–27. 2015.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Grimley PM, Dong F and Rui H: Stat5a and
Stat5b: Fraternal twins of signal transduction and transcriptional
activation. Cytokine Growth Factor Rev. 10:131–157. 1999.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Kanai T, Jenks J and Nadeau KC: The STAT5b
pathway defect and autoimmunity. Front Immunol.
3(234)2012.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Nadeau K, Hwa V and Rosenfeld RG: STAT5b
deficiency: An unsuspected cause of growth failure,
immunodeficiency, and severe pulmonary disease. J Pediatr.
158:701–708. 2011.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Zare F, Dehghan-Manshadi M and Mirshafiey
A: The signal transducer and activator of transcription factors
lodge in immunopathogenesis of rheumatoid arthritis. Reumatismo.
67:127–137. 2015.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Okada Y, Wu D, Trynka G, Raj T, Terao C,
Ikari K, Kochi Y, Ohmura K, Suzuki A, Yoshida S, et al: Genetics of
rheumatoid arthritis contributes to biology and drug discovery.
Nature. 506:376–381. 2014.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Xu WD, Pan HF, Ye DQ and Xu Y: Targeting
IRF4 in autoimmune diseases. Autoimmun Rev. 11:918–924.
2012.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Biswas PS, Gupta S, Stirzaker RA, Kumar V,
Jessberger R, Lu TT, Bhagat G and Pernis AB: Dual regulation of
IRF4 function in T and B cells is required for the coordination of
T-B cell interactions and the prevention of autoimmunity. J Exp
Med. 209:581–596. 2012.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Hwang ES: Transcriptional regulation of T
helper 17 cell differentiation. Yonsei Med J. 51:484–491.
2010.PubMed/NCBI View Article : Google Scholar
|
